Alembic Pharma gets final USFDA nod for generic formoterol fumarate inhalation solution

Alembic Pharma gets final USFDA nod for generic formoterol fumarate inhalation solution The approval for the abbreviated new drug application (ANDA) for formoterol fumarate inhalation solution is for 20 mcg/2 ml per unit-dose vial.

No comments:

Post a Comment